Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
No feed items found.
LATEST NEWS
- Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers
- Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin
- PLACID study: A randomized trial comparing the efficacy and safety of inhaled loxapine vs intramuscular aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
- Systemic hemodynamic response to terlipressin predicts development of hepatorenal syndrome and survival in advanced cirrhosis
- Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders
PHARMACOLOGY
- The sex disparity persists in prevention of cardiovascular disease in women with statin therapy compared with men
- The effect of aliskiren on exercise capacity in older patients with heart failure and preserved ejection fraction: A randomized, placebo-controlled, double-blind trial
- Single and dual antiplatelet therapy in elderly patients of medically managed myocardial infarction
- Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
- Effect of antazoline on electrophysiological properties of atrial muscle and conduction system of the heart
CLINICAL PHARMACOLOGY
- Diaphragm disease in advanced ovarian cancer: Predictability of pre-operative imaging and safety of surgical intervention
- Model to determine risk of pancreatic cancer in patients with new-onset diabetes
- Uptake, results, and outcomes of germline multiple-gene sequencing after diagnosis of breast cancer
- Peritoneal carcinomatosis index as a predictor of diaphragmatic involvement in stage III and IV ovarian cancer
- [<sup>177</sup>Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): A single-centre, single-arm, phase 2 study
ONCOLOGY
